Introduction
The phrase 'endocrine disruption' has seemingly become inextricably linked with terms like 'environmental oestrogens' and 'falling sperm counts'. While these connections aid understanding about these issues, they represent a simplified view of the field of endocrine disruption. There is currently no strong data to suggest that environmental endocrine disrupters (EDCs) are responsible for the observed disintegration in human male reproductive health, but there are secular trends to suggest that it is declining. There is, however, very good evidence that lifestyle factors (e.g. smoking, alcohol consumption and/or use of cosmetics) can have an impact on fertility (Sharpe & Franks 2002; Sharpe & Irvine, 2004) . Similarly, the notion that all EDCs act by mimicking oestrogen (environmental oestrogens) is too simplistic. The current literature illustrates that EDCs can act as oestrogens, anti-oestrogens, anti-androgens, steroidogenic enzyme inhibitors and can also act via interaction with the thyroid hormones and their receptors, or within the brain and the hypothalamo-pituitary axis, as well as the immune system (Fisher, 2004; Jana et al., 2006; 2010a) . Reports of declining sperm counts over the past 50 years and other disturbing trends alerted scientists to the possibility that exposure to chemicals in the environment may damage male reproductive health (Carlsen et al., 1992) . Testicular cancer, the most common malignancy in men 15-44 years of age, has increased markedly in incidence in this century in virtually all countries studied. The incidence of hypospadias, a developmental malformation of the male urethra, appears to be increasing worldwide. Cryptorchidism (undescended testicle), another developmental defect, may have increased in some human populations and appears to be increasing in wildlife (Toppari et al., 1996; Fisher, 2004 , Sharpe, 2010 . The causes of these trends have not been identified and relevant toxicological data about male reproductive effects of environmental toxicants are limited. Recent research efforts have blood-testis barrier (BTB; Walker & Cheng, 2005 ). There are three major phases of spermatogenesis: (1) spermatogonial phase, (2) spermatocyte phase, and (3) spermatid phase (Figure 2 ). In the first phase the diploid spermatogonia undergo mitosis and create stem cells and diploid primary spermatocytes. During the second phase the primary spermatocytes undergo two rounds of meiosis, producing haploid spermatids. Finally, the spermatids begin a differentiation phase, sometimes referred to as spermiogenesis, during which the immature gametes develop into mature spermatozoa (O'Donnell et al., 2001 ). Spermatids continue their differentiation (spermiogenesis) while physically associated with the Sertoli cells. Spermiogenesis includes polarization of the spermatid, formation of the acrosome cap and flagellum, condensation, elongation of the nucleus, and cytoplasmic remodelling to produce the characteristic appearance of the mature spermatozoa. Spermatozoa are morphologically mature but immotile and are then released into the lumen of the seminiferous tubules (spermiation). At this stage these immotile testicular spermatozoa are not yet capable of fertilization (O'Donnell et al., 2001 ). The BTB between Sertoli cells comprises a co-existing tight junction (TJ), desmosome, gap junction and a testisspecific adherens junction (AJ) called the basal ectoplasmic specialization (ES). The basal ES is typified by the presence of actin filament bundles 'sandwiched' between the plasma membrane and the cisternae of endoplasmic reticulum in two neighbouring Sertoli cells.
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However, recent studies show that the unique structural aspects of the BTB, such as the presence of focal adhesion protein FAK, also render the testis highly susceptible to damage from environmental toxicants. Third, during spermiogenesis when round spermatids differentiate into elongated spermatids, genetic material in the spermatid head condense to form the tightly packed nucleus with the formation of an acrosome above the head region and elongation of the spermatid tail. During this time, spermatids migrate towards the adluminal compartment of the seminiferous tubule until elongated spermatids are released into the tubule lumen via the disassembly of another ES, the apical ES, at spermiation. The apical ES anchors developing spermatids in the seminiferous epithelium until they are fully developed. Thus, disruption of the apical ES (e.g. by environmental toxicants) causes the premature release of spermatids that are structurally defective (e.g. lack of acrosome and/or tail) and which are incapable of fertilizing the ovum (Wong & Cheng, 2011) . Fig. 2 . The process of normal mammalian spermatogenesis with three major phases: (1) spermatogonial phase, (2) spermatocyte phase, and (3) spermatid phase.
Sperm maturation
The immotile spermatozoa are transported from the lumen of the seminiferous tubules by peristaltic contractions of adjacent myoid cells. The spermatozoa are suspended in a fluid secreted by Sertoli cells and migrate through a series of ductules within the testis (rete testis), passing through the efferent ductules and eventually entering the epididymis. The efferent ductules concentrate the spermatozoa by reabsorbing fluid (O'Donnell et al., 2001 ). There is evidence from transgenic mice that this fluid resorption is regulated by estrogen (Hess et al., 1997) . The segments of the epididymis, caput, corpus, and cauda secrete proteins, and endocytose secreted proteins from the epididymal lumen to contribute to the maturation of the spermatozoa (O' Donnell et al., 2001) . It is within the epididymis that the spermatozoa gain motility machinery. However, these spermatozoa remain immotile as they are pushed through the rest of the reproductive tissues via peristaltic contractions. It is during this final passage that seminal fluid is produced by the seminal vesicles, which contributes about 70% to the semen, and the prostate gland, which contributes another 10-
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hypospadias. This will allow the monitoring of future trends and allow international comparisons on the incidences of these disorders. However, two male genital birth defects, hypospadias and cryptorchidism, both apparently representing mild degrees of feminization, have become important in the ongoing debate regarding the significance of endocrine disruptors or other environmental influences on male development (Sharpe & Skakkebaek, 1993) . Several researchers have reported increases in each of these defects in the past three decades. To evaluate the hypothesis of common etiologies, pre-and peri-natal determinants of hypospadias, cryptorchidism, testicular cancer, and infertility are under investigation. Abnormal sex hormone exposure during critical periods of development has been postulated as a likely shared pathologic mechanism (Toppari et al., 1996 ).
There is a link between these male reproductive health issues
The strongest evidence suggesting a link between these male reproductive tract disorders, aside from the (largely imperfect) data which suggests they are all increasing in incidence, is the fact that epidemiologically the occurrence of one disorder is a risk factor for the occurrence of another (Skakkebaek et al., 2001 , Sharpe, 2003 . This has led to the proposal that low sperm counts, hypospadias, cryptorchidism and testicular germ cell cancer are interrelated disorders comprising a 'testicular dysgenesis syndrome' (TDS; Skakkebaek et al., 2001 , Sharpe, 2003 , 2010 ; Figure 3 ). The disorders that comprise TDS all have their roots in fetal development, suggesting that a possible causal link lies in abnormal hormone synthesis or action during reproductive tract development. From the historical literature, it is well known that the administration of diethylstilboestrol (DES; a potent synthetic oestrogen) to pregnant humans and rodents causes reproductive tract abnormalities in the offspring (Stillman, 1982) . In male rodents, neonatal administration of DES induces a reduction in the number of Sertoli cells (the major somatic cell type which supports spermatogenesis) . There is also data suggesting DES administration to humans induces an increase in the incidence of cryptorchidism, although it is less certain whether hypospadias and testicular cancer show any significant increase (Stillman, 1982) . DES only induces male reproductive tract abnormalities after administration at very high doses, which are probably not relevant to environmental considerations. However, what is of more concern is that, when administered at high doses, DES and other potent oestrogens are capable of reducing androgen levels and expression of the androgen receptor protein relative to control rats (McKinnell et al., 2001 , Rivas et al., 2002 . This raises the important question of whether some of the genital tract abnormalities that arise from in utero administration of potent oestrogens are caused by lowered androgen levels and/or action.
Anti-androgenic compounds in the environment
There are a number of commonly used environmental chemicals that have been identified as having anti-androgenic properties. These chemicals have been administered to pregnant rodents during the period of reproductive tract development. When the male pups were examined, they displayed many of the abnormalities associated with flutamide administration. Some chemicals (vinclozolin, procymidone, linuron, p,p′DDE (1,1,1-dichloro-2,2-bis(p-chlorophenyl)ethane) act as androgen receptor antagonists, others (phthalate esters) reduce androgen synthesis, but it is likely that other modes of action are also involved in the toxicity induced by these compounds (Gray et al.,2001 ). The following sections provide information on a few well-characterised examples of anti-androgenic compounds (i.e. vinclozolin, linuron, p,p′ DDE and phthalates etc.) and common environmental toxins reported to be involved in male reproductive toxicity. 
Polychlorinated Biphenyls (PCB)
PCB make up a group of synthetic organic chemicals containing about 200 individual compounds. Some PCB bind to ERs and consequently PCB may exert their toxic effects through estrogenic activity (McKinney & Waller, 1998) . Alternatively, some PCB may produce reproductive toxicity through the production of free radicals. Rats exposed to mixtures of PCB demonstrated decreased superoxide dismutase and catalase activity in the testes following exposure (Peltola et al., 1994) . PCB congeners have different mechanisms of action and therefore different effects on biological systems. Longitudinal studies of children with in utero or lactational exposure to PCB and other environmental chemicals are essential to assess the long-term effects of endocrine disruption. Prenatal and lactational exposure to PCB may exert adverse effects on male reproduction during subsequent adulthood. A wellstudied population exposed to PCB/PCDF-contaminated rice oil (Yu-Cheng exposure;
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Taiwan 1978-79) was followed to determine effects on male reproductive health. Median serum PCB levels measured in Yu-Cheng mothers was 26.8 ng/ml: a relatively high PCB exposure that would be expected to affect fetal development. Sexual development and semen quality were evaluated in Yu-Cheng sons, aged 16 yr and older. Seminal volume and sperm concentration were not different between exposed and control boys. However, proportions of sperm with normal morphology and motility were reduced in exposed boys (Guo et al., 2000) . The effects of PCB exposure on semen quality in men from the general population appear to affect differentiation of spermatids (spermiogenesis) and posttesticular development (sperm maturation), which would manifest as decreased sperm morphology and motility, respectively. Further studies of PCB exposure-both individual congeners and PCB mixtures-and sperm parameters are required.
DDT and p,p ′-DDE
The persistent pesticide, DDT, is broken down in the environment, and one of its metabolites is p,p′-DDE, which has been shown to act as an androgen receptor antagonist both in vivo and in vitro . Studies in which p,p′-DDE was administered to rats during development (gestational day (GD)14-18; 100 mg/kg/day) affected androgendependent aspects of male development such that it reduced anogenital distance, caused nipple retention and, depending on the rat strain, induced hypospadias (You et al., 1998) . Another DDT derivative, methoxychlor and its metabolites, have been shown to interact with both oestrogen receptors and the androgen receptor (AR). The methoxychlor metabolite, 1,1-Trichloro-2,2-bis (4 hydroxyphenyl) ethane, is an oestrogen receptor (ER)-agonist, an ER-antagonist and an androgen receptor (AR) antagonist (Gray et al., 2001 ). This illustrates that these chemicals may act by more than one mechanism to induce effects on the exposed population. Moreover, several population studies conducted to examine the effects of DDT and metabolite exposure on male reproductive health support the hypothesis that DDT exposure is related to reduced semen quality. Significantly higher seminal concentrations of p,p′-DDE were also reported in infertile patients compared to a fertile control group in India. Seminal fluid levels of fructose, -glutamyl transpeptidase, and acid phosphatase were positively correlated with p,p′-DDE concentrations in infertile men. The high concentration of fructose, a marker for seminal vesicle function and an important energy source for sperm, may indicate non-utilization of fructose by sperm. DDT exposure may be associated with abnormal metabolism in sperm, including decreased fuel utilization, in infertile men (Pant et al., 2004) . Mexican men living in the areas where DDT was used for malaria control, but without occupational exposure to DDT, exhibited serum levels of p,p′-DDE approximately 350-fold greater than Canadian men exposed to background environmental levels. p,p′-DDE concentrations in the Mexican men were correlated with increases in SHBG concentration and negatively correlated with testosterone levels. Both semen volume and total sperm number were inversely correlated to p,p'-DDE levels. Thus, androgen levels and semen quality are adversely affected by high p,p′-DDE body burden (Ayotte et al., 2001 ). The studies examining DDT exposure and semen quality report consistent effects on sperm motility and sperm morphology, similar to the PCB studies. The increased SHBG concentrations associated with serum p,p′-DDE described by Ayotte et al.,(2001) provides a possible mechanism for observed reductions in plasma testosterone and sperm number. By inducing SHBG synthesis, p,p′-DDE may exert its antiandrogenic effects by reducing the amount of bioavailable testosterone, thereby impairing spermatogenesis.
Further, more extensive correlation studies on the serum levels of DDT and metabolites in mothers of infertile men are required. These studies would provide insight into the effects of in utero exposure to DDT on semen quality of adult males.
Dioxins
Tetrachlodibenzo-p-dioxin (TCDD) is a carcinogen, demonstrated to target the endocrine system in experimental animals. Humans are exposed to dioxins through pulp and paper industry emissions, use of contaminated herbicides (now reduced in industrialized countries), and waste incineration emissions. Dioxins are lipophilic, slowly metabolized, and thus are not easily eliminated leading to bioaccumulation. Secondary dioxin exposures include dietary uptake via contaminated breast milk, meat, fish, and other dairy. Dioxins along with polycyclic aromatic hydrocarbons (PAH) and polyhalogenated biphenyls bind to the aryl hydrocarbon receptor (AhR). AhR ligands induce cell proliferation, differentiation, and apoptosis, although the mechanisms of these stimulations are not fully understood. It is known that human sperm possess AhR and may therefore be directly susceptible to dioxin (Khorram et al., 2004) . A range of endocrine effects are reported in experimental animals following dioxin exposure. These include disruption of the HPT axis feedback mechanisms leading to alterations in serum levels of testosterone, dihydrotestosterone (DHT), E2, and LH, as well as modifications of the metabolism processes/events of estrogens and androgens (Birnbaum & Tuomisto, 2000) . There are few published studies reporting human exposure to dioxins. Agent Orange, which contains TCDD as its contaminant, was used during the Vietnam War and exposure was documented in veterans of Operation Ranch Hand (the unit responsible for aerial herbicide spraying in Vietnam from 1962 to 1971; (Stone, 2007) . Detectable TCDD levels in serum and seminal plasma were evident in U.S. veterans two to three decades following their Vietnam military service. Reproductive parameters including serum testosterone, FSH, LH, and testicular abnormalities were not associated with serum TCDD levels in the exposed men. It may be possible that the effects of dioxin on reproductive parameters were no longer evident at the time of the study, several decades after the use of Agent Orange. As semen quality can only be evaluated by follow-up study, the acute effects of exposure to Agent Orange on male reproductive health are unknown. Another study of 101 men from the general population in Belgium assessed TCDD exposure and semen quality. TCDD exposure was measured as dioxin-like activity in serum. Increases in serum dioxin-like activity were associated with decreased seminal volume resulting in elevated sperm concentrations. Total testosterone levels were significantly reduced in men with high serum dioxin-like activity. However, there was no significant association with LH, inhibin B, FSH, total sperm numbers, or sperm morphology (Dhooge et al., 2006) . There are few epidemiological studies evaluating reproductive outcomes and particularly semen quality following TCDD and dioxin exposure. However, it is more relevant to consider the effects of dioxin at environmental concentrations on male reproductive health. A possible mechanism for infertility may be mediated by dioxin interacting with AhR on human sperm with implications for capacitation, acrosome reaction, sperm-egg binding, and fertilization. More studies are required to examine the effects of dioxin on semen quality.
Phthalates esters
Phthalate esters are abundant industrial chemicals used in the production of plastics and are present in many personal care products including cosmetics. Phthalates are a family of www.intechopen.com Environmental Toxicants Induced Male Reproductive Disorders: Identification and Mechanism of Action 483 compounds and only a few induce male reproductive tract abnormalities. Gray et al., (2000) compared the ability of six phthalate esters (diethylhexyl phthalate, DEHP; benzylbutyl phthalate, BBP; diisononyl phthalate, DINP; dimethyl phthalate, DMP; diethyl phthalate, DEP; dioctyl terephthalate, DOTP; all administered at 750 mg/kg body weight from GD14 to postnatal day (PND) 3) to induce malformations of the reproductive tract. This study assessed changes in many androgenic endpoints and found that only DEHP, BBP and to a lesser degree DINP induced alterations in all aspects of androgen-regulated male reproductive endpoints. Exposure to diethyl hexyl and dibutyl phthalates is associated with adverse effects on sperm motility (Fredricsson et al., 1993) . Animal studies consistently demonstrated that phthalate esters are male reproductive toxicants (Park et al., 2002) , with exposure associated with testicular atrophy, spermatogenetic cell loss, and damage to the Sertoli cell population. Phthalate monoesters target Sertoli cell functions in supporting the spermatogenesis process. This may be due to the effect of phthalates in reducing the ability of Sertoli cells to respond to FSH (Hauser et al., 2005) . Initial reports on the effects of phthalates on male reproductive tract development focussed on the gross changes such as reduced anogenital distance, hypospadias, malformed epididymis and, in later studies, nipple retention (Mylchreest et al., 2000) . Only a few studies give a more detailed account of the histological changes observed in the testis after in utero phthalate exposure and demonstrate that the fetal testis is directly affected by phthalates during fetal and neonatal testis differentiation Fisher et al., 2003) . Some of these alterations are permanent and affect the function of the testis in adult life and are similar to the histological changes which are now being shown in patients with testicur dysgenesis syndrome (TDS; Skakkebaek et al., 2003) . The production of testosterone is critical for the normal masculinization of the male reproductive tract, as already discussed. It has been shown that DBP and DEHP are both capable of inhibiting the production of testosterone by the fetal testis Fisher et al., 2003) . Testosterone synthesis by the fetal testis is first detectable by GD15, reaches a peak at around GD18/19, and remains high until birth. However, phthalate treatment induces a 60-85% reduction in testosterone synthesis during this critical developmental window, reducing testosterone levels to a similar level to those found in females . This reduction in testosterone is a factor in the occurrence of hypospadias and cryptorchidism observed after phthalate treatment. This is not to suggest that phthalate exposure causes TDS in humans, merely that the administration of very high doses of DBP to pregnant rats induces a TDS-like syndrome in the male offspring that shows many analogous features to human TDS. It is plausible, given how highly conserved the pathways of fetal development are, that phthalate administration may disrupt some common mechanistic pathways which if altered in humans could be helpful in determining the pathogenesis of human TDS. In both the human syndrome and the rodent model, abnormal testicular development or dysgenesis is evident by the abnormal organisation of these tissues. In humans, histological evidence of testicular dysgenesis (immature seminiferous tubules with undifferentiated Sertoli cells, microcalcifications and Sertoli cell only (SCO) tubules, Leydig cell hyperplasia, morphologically distorted tubules and the presence of carcinoma in situ (CIS) cells) have been found in biopsies of the contralateral testes of testicular germ cell cancer patients and in biopsies from patients with infertility, hypospadias and cryptorchidism . These studies support the hypothesis that all of these disorders (low sperm counts, 484 cryptorchidism, hypospadias and testicular cancer) are associated with TDS. The in utero administration of DBP to rodents during the sensitive period of tissue morphogenesis permanently alters the testis and produces foci of testicular dysgenesis (immature seminiferous tubules with undifferentiated Sertoli cells, SCO tubules, Leydig cell hyperplasia, morphologically distorted tubules and the presence of abnormal germ cells) which persist in the adult animal (Fisher et al., 2003) . The downstream consequences of altered Sertoli cell (and subsequently Leydig cell) function may be a key cause of many of the observed changes in both human TDS and the rat TDS-like model due to the central role of this cell type in driving testis morphogenesis in both rodents and humans. Several population studies evaluated phthalate ester exposure and semen quality. A randomized controlled study of men with unexplained infertility reported a negative correlation between seminal plasma phthalate ester concentration and sperm morphology (Rozati et al., 2002) . Environmental phthalate levels measured by urinary metabolite, were reported to be associated with increased DNA damage in sperm (Duty et al., 2003) . The studies measuring phthalate levels and semen quality seem to suggest an effect on sperm morphology and motility, rather than on total sperm numbers. Hauser et al.,(2005) suggest a mechanism by which PCB exposure may extend the bioavailability of phthalate metabolites, which in turn adversely affect semen quality. As human exposure consists of phthalate mixtures, along with xenobiotics, studies designed to test or measure single phthalate esters fail to appropriately characterize risks associated with these chemicals.
Phytoestrogens
Phytoestrogens are nonsteroidal plant-derived compounds with potent estrogenic activity. There are four main groups of phytoestrogens: isoflavonoids, flavonoids, coumestans, and lignans. Phytoestrogens exert their action via multiple mechanisms. Phytoestrogens interact with both ER and ER , thereby inducing weak estrogenic and antiestrogenic actions (Kuiper et al., 1998) . Coumestrol and genistein, two phytoestrogens, exhibit a higher affinity for ERß than for ER (Whitten & Naftolin, 1998) . Some phytoestrogens exert an inhibitory action on steroidogenic enzymes (Strauss et al., 1998) . For example, isoflavonoids and lignans inhibit 5 -reductase activity, thereby reducing the conversion of testosterone to the active form DHT. A number of phytoestrogens, including lignans, isoflavonoids daidzein and equol, enterolactone, and genistein, were found to induce SHBG production in the liver (Adlercreutz et al., 1987) . There are few studies measuring the effects of phytoestrogens on semen parameters in men. The effects of short-term phytoestrogen supplementation on semen quality and endocrine function were examined in a group of young, healthy males. Subjects received 500 mg supplements containing 40 mg of phytoestrogens isoflavones genistein, daidzein, and glycitein daily for 2 months and donated semen and blood for 2 months before and 4 months after supplementation (Mitchell et al., 2001 ). Testicular volume was not influenced by phytoestrogen supplementation; nor did serum E2, testosterone, FSH, or LH differ between the supplement-taking group and the control group who did not take supplements. Finally, phytoestrogen supplementation did not produce changes in seminal volume, sperm concentration, sperm count, and sperm motility (Mitchell et al., 2001 ). A case report described therapeutic phytoestrogen supplementation (80 mg/day for 6 months) to an oligospermic man, which did sufficiently improve semen parameters such that intrauterine insemination was performed and the couple was able to conceive (Casini et al., 2006) . To date, evidence linking dietary consumption of phytoestrogens and reduced semen quality is insufficient and requires further study.
Pesticides, fungicides and herbicides
The U.S Environmental Protection Agency (EPA) defines a pesticide as "any substance or mixture of substances intended for preventing, destroying, repelling, or lessening the damage of any pest," which may include plants, weeds, animals, insects, and fungus. Many epidemiological studies use the generic term pesticides to refer to a broad range of structurally unrelated compounds with different mechanisms of action, biological targets, and target pests. Epidemiological studies that evaluate the effects of these chemicals on male reproductive parameters often lack direct, quantitative measures of exposure. A study of participants from The Study for Future Families evaluated semen quality and pesticide exposures in male partners of pregnant women attending prenatal clinics in Missouri and Minnesota (Swan et al., 2003) Urinary levels of metabolites from the pesticides alachlor, diazinon, atrazine, and metolochlor were detected more often in men from Missouri, representative of the pesticides used in the agricultural practices of this state. Pesticide metabolites of chlorpyrifos/chlorpyrifos methyl (3,5,6-trichloropyridinol) and methyl parathion (4-nitrophenol) were detected more frequently in men from Minnesota. For the Missouri group, there was an association between low semen quality and urinary levels of chlorpyrifos and parathion metabolites. Further, increased levels of herbicides alachlor and metoachlor were associated with decreased sperm morphology and concentration. In contrast, there was no association between levels of any of these pesticides and their metabolites and semen parameters within the Minnesota group (Swan et al., 2003) . A followup study focused on the men from Missouri, using a nested case-control design (cases: men with low semen parameters; controls: men with normal parameters). Urinary levels of metabolites of eight currently used pesticides were measured and correlated with semen quality. Men with elevated metabolite levels of alachlor and atrazine (herbicides) and diazinon (2-isopropoxy-4-methyl-pyrimidinol insecticide) were significantly more likely to have poor semen quality than controls (Swan, 2006) . This study provide evidence that environmental exposures differ between regions, even within the same country. Different agricultural practices will create regional variation in the amounts and types of pesticides used, leading to differences in biological effects. A study in male infertility patients in Massachusetts measured urinary metabolites of carbaryl/naphthalene and chlorpyrifos. Sperm concentration, motility, and, to a lesser extent, morphology were reduced in men with elevated exposure to carbaryl/naphthalene (as measured by urinary levels of the metabolite 1-naphthol) and to chlorpyrifos (as measured by urinary levels of the metabolite 3,5,6-trichloro-2-pyridinol [TCPY]) (Meeker et al., 2004) . The mechanism of action of carbaryl may be related to the production of reactive oxygen species (ROS) rather than endocrine disruption. Carbaryl produced lipid peroxidation at low concentrations, which in turn induced the sperm plasma membrane to lose its fluidity and integrity, thereby impairing sperm motility (Meeker et al., 2004) . Generally, the studies reviewed here demonstrated a relationship between pesticide exposure and reduced semen quality. However, toxicology studies using animal models are essential to understand the biological mechanisms underlying the adverse reproductive affects caused by pesticide exposure in the male.
Vinclozolin
Vinclozolin is a dicarboximide fungicide that has two active metabolites, M1 and M2, which have anti-androgenic properties. In vivo and in vitro experiments demonstrate that these compounds act as potent androgen receptor antagonists, and administration to pregnant 486 rats results in abnormalities of androgen-regulated sexual differentiation similar to those induced by flutamide, e.g. reduced anogenital distance, nipple retention, hypospadias, undescended testes and small or absent accessory glands (Gray et al., 2001) . Studies have tried to define the 'sensitive window' for exposure to vinclozolin, and have determined that administration to pregnant rats during gestational day (GD) 14-19 induced reproductive tract malformations, with treatment over GD16-17 causing the most severe malformations (Wolf et al., 2000) . This illustrates that the whole period of male reproductive tract differentiation is sensitive to the effects of anti-androgens.
Linuron
Linuron is a urea-based herbicide which acts as a weak androgen receptor antagonist in vitro and in vivo, and disrupts androgen-dependent male reproductive tract development after gestational exposure (Gray et al., 2001 ). When administered to pregnant rats (GD 14-18; 100 mg/ kg/day) the male pups displayed a reduced anogenital distance and retention of areolas (Gray et al., 1999) . Linuron failed to induce either hypospadias or undescended testes, suggesting that linuron affects testosterone-but not DHT-mediated development, though how this occurs is not known (McIntyre et al., 2002).
Tobacco smoke
It is beyond the scope of this review to provide a detailed review of the literature on cigarette smoking and semen quality. However, PAH (polycyclic aromatic hydrocarbons), the major carcinogenic components of cigarette smoke (Vine, 1996) , were found to activate aryl hydrocarbon receptor (AhR), suggesting that tobacco smoke may represent a chemical mixture with endocrine disrupting activity. There is extensive evidence demonstrating that exposure to tobacco smoke is associated with reduced semen quality (Vine, 1996 ). An inverse dose-dependent relationship between smoking and semen volume, total sperm count, and percent motile sperm was reported following a large cross-sectional study of 2542 healthy Danish men. Sperm concentration was 19% lower in heavy smokers compared to non-smokers. Serum LH and testosterone were positively correlated with smoking (Ramlau-Hansen et al., 2007). The incidence of bilateral cryptorchidism in a sample of cryptorchid Danish boys was increased in children of smoking mothers. Testicular biopsies from boys exposed in utero/neonatal to tobacco smoke demonstrated a decreased number of spermatogonia and gonocytes per tubule cross section (Thorup et al., 2006) . Similarly, a large cross-sectional European study of 889 Danish men, 221 men from Norway, 313 Lithuanian men, and 190 men from Estonia reported reductions of sperm concentrations by 20% in sons exposed to prenatal tobacco smoke (Jensen et al., 2004) , while a separate study described an inverse dose-dependent association between sperm concentration and prenatal tobacco exposure, measured in adult sons of 522 Danish women (Jensen et al., 2005) . The association between impaired semen quality and smoking is fairly well established (Vine, 1996) . Although epidemiological studies of male reproductive function were designed to avoid the confounding effects of smoking, by limiting samples to non-smokers or segmenting samples according to smoking status, the interaction effects of tobacco smoke, alcohol, and other lifestyle factors are often not considered. An important study by Robbins et al.,(1997) did investigate the interactions of caffeine, alcohol, and cigarette smoking on sperm aneuploidy, determining that incidence of sperm abnormalities decreased after controlling for age and other lifestyle factors.
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Medications and male reproductive toxicity
There are a variety of prescription medications that can lead to male infertility, often temporary but sometimes permanent. Arthritis medication, depression drugs, high blood pressure medication, drugs for digestive problems as well as antibiotics and cancer drugs are just a few of the medications that can lead to interferences with sperm production, sexual function and ejaculation (Nudell et al., 2002) . Here is a look at some of the common medications and drugs that can cause a man to experience fertility problems.
Antihypertensive
Although most men who are treated for hypertension are older, the recent focus on the importance of blood pressure control has led to greater numbers of younger patients on antihypertensives. Many of these medications are commonly associated with erectile dysfunction but most do not directly affect fertility. One exception is spironolactone, which acts as an anti-androgen and has been associated with impaired semen quality. Calcium channel blockers (e.g. nifedipine) have been reported to cause reversible functional defects in sperm, impairing their ability to fertilize eggs without affecting sperm production or standard semen analysis parameters; however, not all investigators report these types of effects. Diuretics can affect function by decreasing penile blood flow, and beta-blockers may affect libido and erectile function (Benoff et al., 1994 ).
Hormones
Diethylstilbestrol (DES) was given to pregnant women in the 1950s, and reports of epididymal cysts and cryptorchidism (undescended testes) in males with prenatal DES exposure have raised concerns about fertility; however, follow-up studies on adult men with prenatal DES exposure have revealed no adverse effects on fertility (Wilcox et al., 1995) . Exogenous androgens are well known to induce hypogonadotropic hypogonadism. This may be induced directly by testosterone supplementation or by use of synthetic anabolic steroids, leading to azoospermia. This hypogonadism is usually reversible but may take 3 to 6 months, and some patients do not recover pituitary function. It is important to remember that testosterone replacement therapy in younger men may lead to infertility. Dehydroepiandrosterone (DHEA) is a natural steroid prohormone precursor of androsterone, testosterone, and estrogen. DHEA is commonly taken and easily available over the counter. Antiandrogens and estrogens can adversely affect fertility by altering the HPG axis or decreasing libido or erectile function, while progesterones act by decreasing libido or erectile function (Nudell et al., 2002 ).
Antiandrogens
Finasteride and dutasteride are antiandrogens that act by inhibiting 5-alpha-reductase. Finasteride has also been used to treat male-pattern baldness. These drugs increase the risk of low ejaculate volumes and libido, as well as cause erectile and ejaculatory dysfunction; however, men taking low doses of finasteride for hair loss have shown no changes in semen parameters (Overstreet et al., 1999 ).
Antibiotics
Many antibiotics have been reported to exert adverse effects on male fertility; however, there are few human data on the majority of these medications. High doses of nitrofurantoin have been reported to cause early maturation arrest at the primary spermatocyte stage but the more common short-term low-dose therapy is not likely detrimental. While in vitro data on erythromycin, tetracycline, and gentamycin suggest the potential for adverse effects on fertility, documentation of an in vivo effect in humans is lacking (Hargreaves et al., 1998) . Sulfasalazine, used in the treatment of ulcerative colitis, is well known to cause defects in human sperm concentration and motility. Aminoglycosides, type of antibiotics is generally used for serious bacterial infections, like TB, and are administered under medical supervision. Aminoglycosides can negatively impact sperm production while neomycin has been shown to reduce both sperm count and motility. Macrolides, in addition to being used to treat chlamydia and Legionnaires disease, macrolides are similar to penicillin and can be used in place of it in people with a penicillin allergy. Macrolides research has mainly focused on animals, where it has been found that the antibiotic can decrease sperm motility as well as kill off sperm. It is believed that the antibiotic produces similar results in humans (Schlegel et al., 1991 ).
Psychotherapeutic agents
Many psychotherapeutic agents affect male fertility by suppressing the HPG axis and decreasing erectile function and libido. Indeed, one of the most significant side effects of the antidepressants is elevation of serum prolactin, leading to significant but reversible suppression of spermatogenesis (Nudell et al., 2002) . Psychotherapeutic agents include antipsychotics, tricyclic and selective serotonin reuptake inhibitor (SSRI) or selective norepinephrine reuptake inhibitor (SNRI) antidepressants, monoamine oxidase inhibitors (MAOIs), phenothiazines, and lithium. There are now large numbers of patients taking SSRI or SNRI medications, many of which have significant fertility effects.
Anticancer drugs
Doxorubicin hydrochloride, Goserelin acetate, methotrexate, or fluorouracil all are the drugs used to treat various types of cancer. However, these drugs have significant side effects on sexual behaviour, altered fertility and sperm count (Nudell et al., 2002 ).
Chemotherapeutic agents
Chemotherapy for the treatment of cancer can have devastating effects on male fertility through the impairment of spermatogenesis; indeed, alkylating agents, antimetabolites, and the vinca alkaloids are all gonadotoxins. The alkylating agent, cyclophosphamide alters male fertility; treatment with 1-2 mg/kg for more than 4 months increases the incidence of azospermia and oligospermia in adult male patients (Qureshi et al., 1972) . In patients with testicular cancer, the cumulative dose of cisplatin determines whether spermatogenesis is impaired irreversibly. Most patients will become azoospermic, with the majority recovering spermatogenesis within 4 years. The majority of Hodgkin's disease or leukemia patients become azoospermic after chemotherapy; this may or may not lead to permanent sterility. After treatment with mitoxantrone, vincristine, vinblastine, and prednisone combination therapy plus abdominal radiotherapy for Hodgkin's disease, sperm counts and motility were restored to pre-treatment levels in most patients (Magelseen et al., 2006).
Miscellaneous medications
Cimetidine has been reported to have antiandrogenic effects that induce gynecomastia and decreases in sperm count. Immune modulators are commonly used but, unfortunately, clear human data regarding male fertility for interferon or the immunosuppressant mycophenolate mofetil are lacking. Although cyclosporine has been found to induce www.intechopen.com Environmental Toxicants Induced Male Reproductive Disorders: Identification and Mechanism of Action 489 impaired fertility in rats, there are no human data available (Nudell et al., 2002) . Epilepsy has been associated with decreased testosterone levels and increased estrogen levels leading to reductions in libido and to erectile dysfunction. Medications used to treat epilepsy (eg, valproate, oxcarbazepine, and carbamazepine) may worsen hormonal abnormalities and have been associated with some sperm morphologic defects (Isojarvi et al., 2004 ).
Recreational and illicit substances and male reproductive toxicity
Heavy marijuana use has been associated with gynecomastia, decreased serum testosterone levels, decreased sperm concentration, and pyospermia (white cells in the semen indicating possible infection) (Close et al., 1990) . Patients experience variable sensitivity to marijuana, and it may take 2 to 3 months for symptoms to improve. Oligospermia (abnormally low sperm concentration in the ejaculate) and defects in sperm morphology and motility have been reported in users of cocaine. Opiates have also been shown to decrease libido and erectile function through induction of hypogonadotropic hypogonadism. This also is important to note when prescribing opioids for pain. Chronic opioid use whether, oral or intrathecal, may lead to sexual dysfunction (Bracken et al., 1990) . Cumulative evidence suggests that cigarette smoking may have a deleterious effect on male fertility by reducing sperm production, motility, and morphology. Cigarette smoking may also lead to development of pyospermia, decreased sperm penetration, and hormonal alterations (Nudell et al., 2002; Close et al., 1990 ). Long-term abuse of alcohol has detrimental effects in the HPG axis. Alcoholics exhibit significant decreases in semen volume, sperm count, motility, and number of morphologically normal sperm. They also show signs of pyospermia. Alcohol in excess can thus exert profound deleterious effects on all aspects of the male reproductive system. However, there is no evidence that moderate alcohol intake impairs male fertility (Nudell et 
Common environmental Toxicants
Common uses and routes of exposure The effects on male reproductive system of phenol/ formaldehyde resins (Bakelite) and in the production of octylphenol ethoxylates, and used in the formulation of printing inks and in tyre manufacture DDT (break-down product DDE).
DDT is an insecticide which was used extensively on crops, but is now only used in a few countries against the malaria-bearing mosquito. DDT and DDE last in the soil for a very long time, potentially for hundreds of years. Unfortunately, due to this persistence, it is still found in some produce, such as vegetables, fish and liver. DDE is also found as a persistent contaminant in our bodies. The DDT breakdown product or metabolite, p,p'-DDE, is able to block testosterone. 
Identifying hazards
A discrepancy exists between the number of chemicals in commerce (approximately 84,000) and the number that have been evaluated in model species for reproductive toxicity potential (4,000) (U.S. EPA 1998a and 1998b). It is not feasible to allocate additional resources to test the 80,000 or so untested chemicals through traditional testing protocols, particularly given that about 2,000 new chemicals are introduced into commerce each year (U.S. EPA 1998). Instead, new, more rapid methods are needed to screen large numbers of chemicals and to identify those that are potential reproductive hazards. In the near term, top priorities will be to develop the most promising alternative models and to test their ability to appropriately classify the toxicity of sets of known toxicants and non-toxicants.
High-throughput assays
High-throughput assays evaluate the effect of a test substance on a single biologic process using an automated manner that allows thousands or tens of thousands of compounds to be tested in a short time at a reasonable cost. Robotics and genetic engineering make it possible to produce large quantities of receptors or genetically engineered cells for use in these assays. Knowledge about mechanisms of toxicity is often central to the strategy of highthroughput assays. For example, cells are being developed that are bioengineered to express human hormone receptors for estrogens and androgens. These cells can be used for highthroughput chemical screening for steroid hormone receptor affinity or the potential to act as endocrine disruptors. Both isoforms of recombinant human estrogen receptor and human androgen receptor are commercially available for this purpose. Based on the same principles, other batteries of high-throughput assays are available to screen for activity against various receptors and cytochrome P-450 enzyme isoforms (Lawson et al., 2003) . The availability and application of these assays will undoubtedly expand as we understand more about the relevance of each protein in toxicologic processes.
Structure-activity prediction
Methods for predicting activity from structure continue to be developed and refined.
Computer programs use available empirical information about the toxicity of existing compounds and their chemical characteristics to predict whether a new compound will have similar toxicity. These programs have not performed well in the area of reproductive and developmental toxicity, probably because reproductive processes are complex and effects may be elicited through multiple modes and mechanisms. As science progresses and we learn more about mechanisms of toxicity at the molecular level, however, structure-activity computer programs will become more exact and predictive. The best examples are the programs that are being developed and refined for estrogen receptor binding (Tong et al., 1997). Though 4 ,000 chemicals have been tested in model species, few chemicals have been adequately evaluated for reproductive effects in humans and contain a partial list of known human developmental and adult toxicants. Because the interpretation of studies of model species is often not straightforward and because field studies are labor and resource intensive, a systematic approach is needed to select and prioritize chemicals for epidemiologic studies. Moorman et al., (2000) recently proposed a process for selecting chemicals for human field studies. In this process, information gained from model species testing conducted by the National Toxicology Program (NTP) was reviewed for significant adverse reproductive effects and potency of the toxicants. The evaluative process then combined this information with human exposure information available in public databases to arrive at a list of high-priority candidates for studies in humans.
Integration of human studies and tests of model species
New biomarkers for humans and model species
In 1977, men exposed to dibromochloropropane (DBCP), a pesticide that is now banned in the United States, were found to be azoospermic and oligospermic (Whorton et al., 1977) . Currently, a variety of biomarkers are used to assess the potential adverse reproductive effects due to toxic chemical exposures. Bioindicators of sperm production and quality (semen volume, sperm concentration, sperm motility, sperm morphology) are routinely evaluated in ejaculated semen samples in men and in suspensions of epididymal sperm from test species (epididymal sperm reserves, sperm motility, and sperm morphology) (Moline et al., 2000; U.S. EPA 1998a). During the past decade, computer-assisted methods developed to improve and automate the evaluation of sperm motion and morphology have been added to the battery of routine sperm measures, and guidance for their use and interpretation has been made available through a number of workshops (ILSI 1999; Seed et al.,1996) . Furthermore, baseline data on the relationship between various semen or epididymal sperm measures and fertility have emerged from a number of large studies designed to address this question (Zinaman et al.,2000 
Estimating occupational exposure
Establishing that a significant number of workers or members of the general population are or will be exposed to a potential reproductive toxicant is central to priority setting. NIOSH's National Occupational Hazard Survey and National Occupational Exposure Survey conducted in 1972-1974 and 1981-1983 , respectively, has been used extensively to identify substances of common exposure (NIOSH 1978 (NIOSH , 1988 . These surveys are the only comprehensive assessments of general industry where the number of workers potentially exposed to chemical agents has been estimated. However, these databases are outdated and of limited use because they indicate only potential exposure. NIOSH is currently planning a new hazard surveillance activity that will target industry sectors on a rolling basis, beginning with the health care sector. Public health researchers will continue to require updated exposure surveys to keep up with the changing workplace exposures and monitor Chemicals is a new and ongoing assessment of the U.S. population's exposure to environmental chemicals. The first edition of the report presents levels of 27 environmental chemicals, including metals (e.g., lead, mercury, and uranium), cotinine (a marker of tobacco smoke exposure), organophosphate pesticide metabolites, and phthalate metabolites. This is a significant step forward in assessing the potential human toxicity of a class of chemicals known to be reproductive and developmental toxicants in rodents. Improved methods for analysis of exposure, especially of age and time effects, are likely to impact the characterization of occupational exposure in these studies (Richardson and Wing 1998) . Current research approaches usually consider the action of single, unique toxicants on outcomes of interest, creating yet another challenge to drafting a reproductive hazards agenda. The more common human exposure scenario is to mixtures of toxicants at low concentrations, episodically and over the long term. Attention to cumulative exposure over years of a working lifetime and total aggregate exposure to toxicants from multiple exposure sources, as well as classical considerations of exposure routes, must also be addressed. Methodologic approaches must enlarge and mature to consider the effects and modulation of effects mediated by both exposure to mixtures of toxicants and the complexities of exposure mode at low dose and over prolonged duration.
Mechanistic research
Understanding mechanisms of action of toxicants is important for a number of reasons, including a) supporting the biologic plausibility of an observed association between chemical exposure and adverse outcome; b) uncovering common pathways of actions of different agents; c) extrapolating across species for risk assessment; d) improving the predictability of human morbidity from responses of model species; and e) predicting responses to mixed exposures (Lawson et al., 2003) . Mechanistic studies are not new in toxicology; however, new tools in genomics, proteomics, and bioinformatics present unprecedented opportunities to advance our understanding of toxicant action at a molecular level. Genomic information and the ability to screen most or all of the genome of an increasing number of organisms for changes in gene expression are revolutionizing the way in which biologic effects data are gathered. It is now possible to determine the effects of a toxicant exposure on gene expression of most of the genome of mice and rats. This will allow us to generate testable hypotheses about the mechanism of action of toxicants. It will also open up the possibility of identifying markers of exposure or effect specific to a particular insult that can be used in field studies. As with any new technology, a number of problems will need to be overcome for the promise of genomics to be realized. The first will be to manage the large volume of information produced by gene expression experiments. Gene chips may contain thousands or tens of thousands of sequences. Experience shows that any perturbation in a biologic system leads to numerous changes in gene expression. An entire field of bioinformatics is being developed to help collect, organize, and manage the data to identify changes related temporally, by dose, or by metabolic pathway. The second challenge will be to separate those changes in gene expression pivotal to the toxic response from those that are more generalized responses to any stimulus. The third challenge will be to quantitatively relate changes in expression of critical genes with toxicity, which is manifested at a more complex level of biologic organization (i.e., the cell, organ, or organism). Real comfort in this genomic approach will come only with experience and the development of a large database.
Gene-environment interactions
Reproductive toxicants can affect human populations over the total life span, including the in utero and perinatal periods, childhood, puberty, and adulthood. Thus, extending research efforts to address stage-specific sensitivity is recommended. Another emerging approach allows the identification of populations at potentially increased risk from toxicant exposure by characterizing genetic polymorphisms of metabolizing enzymes in exposed cohorts. Such methods may identify vulnerable subpopulations on the basis of inherent (genetic) differences in their ability to metabolize a toxicant.
Identifying genes that increase sensitivity to reproductive toxicants
Genetic factors that elevate risk for disease can be grouped into two categories: those for which having a particular allele conveys a high risk for the disease regardless of other (e.g., environmental) influences and those associated with only small increases in risk of the disease. The latter, termed susceptibility genes are being identified at an increasing rate. The interaction of these alleles with environmental agents or other susceptibility alleles ultimately determines whether the disease will be manifested. Much work has been done to understand the role of these genes for reproductive toxicity.
Potential information from genetics to advance epidemiologic studies
If epidemiologic studies could identify genetic-toxicant interactions by comparing the prevalence of a particular genetic marker (polymorphism) or a group of markers in affected and unaffected populations, this information could be used to target environmental, behavioral, or medical interventions (Khoury 1997) . Ultimately, validation of genetic testing to link a particular genotype with exposure to a specific chemical to the increased prevalence of a particular reproductive disorder would require epidemiologic confirmation (Khoury & Dorman 1998).
Communication
An essential component of future reproductive studies will be improved communication.
Because of the complex mechanisms involved in reproductive research, collaboration across scientific disciplines must be conducted. In addition, notification of research results and recommendations must be communicated to workers and the affected public in a manner that is timely, accessible, and easily understood. A primary goal of reproductive research is to reduce the high percentages of adverse outcomes such as infertility, pregnancy loss, and congenital malformations. Although certain limitations exist that are unique to reproductive research, many advances in technology and methodologies have been recently developed that will aid researchers in their efforts to a) understand mechanisms by which toxicants exert their effects, b) identify populations at risk, and c) evaluate reproductive and developmental hazards to improve public health.
Methods of assessing male reproductive capacity
The determination of sperm concentration, morphology, and motility remains the primary clinical assay for male infertility (WHO, 1999). The WHO guidelines on semen quality provide reference semen parameters as follows: sperm concentration >20 million/ml, 50% motility, and at least 50% normal morphology (WHO, 1999) . Oligospermia is the term for semen with <20 million/ml sperm in ejaculate, and asthenospermia for semen with sperm <50% motility or <25% rapid progressive motility, teratospermia for reduced percent sperm with normal morphology, and azoospermia for the absence of sperm in the ejaculate (Braude & Rowell, 2003) . It is unknown whether endocrine disrupter exposure represents a subset of the environmental risk factors for male infertility, as there are few studies that examine exposure and human semen quality. Moreover, toxicants can affect the male reproductive system at one of several sites or at multiple sites. These sites include the testes, the accessory sex glands, and the central nervous system, including the neuroendocrine system.
The contribution of experimental models
The usefulness of experimental animal models is usually perceived as limited to hazard identification using the test protocols specified by regulatory agencies. However, animal models can also provide valuable support to reproductive risk assessment on many other fronts. If the focus is on human exposure, animal studies can be designed to confirm reproductive toxicity when initial observations in exposed humans are suggestive of an adverse effect. Furthermore, such observations can be extended across a wide range of exposures in animals, using any route of exposure and any specified dose versus time scenario. For example, when human exposure is likely to be acute or intermittent, animal models are ideal for defining critical exposure windows based on developmental stage or for revealing the pathogenesis of an effect at various times after exposure through recovery. This is particularly important with respect to male reproductive effects because alterations in semen quality or fertility may not become evident until sometime after the exposure, particularly if an early stage of spermatogenesis is targeted. A rodent model is most commonly used for the study of reproductive and developmental toxicity (Claudio et al., 1999) . To use toxicology data derived from animal studies to advantage in risk assessment, it is critical to identify and understand species-specific differences in physiology and metabolism that may affect the response to the toxicant in question. Rodent models have, for example, been used to determine the relationship between sperm end points and function (fertility) (Chapin et al., 1997) . Determining that a substance is toxic to the male reproductive system is only the first step: The next step is to examine its mechanisms of toxicity. Mechanistic information allows for predictions about the potential toxicity of individual compounds or complex mixtures in humans, for better understanding of the windows of vulnerability in the development of the male reproductive system, and for developments of possible preventive or curative measures. Acute short-term exposure models combined with serial exposure models give a complete picture of the range of effects (Claudio et al., 1999) . Exposing animals over a long period of time allows for the detection of transgenerational effects from chemicals, such as male-mediated developmental effects. If developmental effects appear, researchers can go back and administer a dose during that critical period of development to refine knowledge about how such problems occur. Early developmental end points measurable in animal research include anogenital distance at birth, testis position, genital malformations, secondary sex characteristics, and serum hormone levels. Acute short-term exposures, on the other hand, can be useful for identifying critical windows of exposure. Acute exposures followed over time can help identify the pathogenesis of a lesion, isolate the cell type that is susceptible to damage (germ cells, spermatocytes, or spermatid), and determine genetic effects, including the repair capability of affected genes. Serial sacrifice studies are best used for identifying the earliest detectable pathologic changes in target organs, cells, or processes. Multigeneration studies, in particular continuous breeding studies, yield the most thorough assessment of the many complex processes that result in reproductive and developmental toxicity.
Epidemiologic approaches
Epidemiologic methods for assessing the impact of hazardous substances on male reproductive health include a) questionnaires to determine reproductive history and sexual function, b) reproductive hormone profiles, and c) semen analysis. The choice of appropriate methodologies to study the effects of reproductive toxicants is predicated on the investigators' understanding of several factors: the nature of the exposed population; the source, the levels, and the known routes of exposure; the organ systems in which a toxicant exerts its actions; the hypothesized mechanisms of a toxicant's actions; and the techniques available to assess the effects of toxicants in the relevant organ systems (Wyrobeck et al., 1997) . Table 2 outlines the methods currently available for assessing the principal targets of male reproductive toxicants in humans--the testes, the accessory sex glands, the neuroendocrine system, and sexual function. Researchers and clinicians interested in male reproductive health and fertility are using increasingly sophisticated methods adapted from the fields of assisted reproductive technology and reproductive toxicology, including assays of sperm function, genetic integrity, and biomarkers of DNA damage. For population-based studies involving occupational groups or communities with environmental exposures, issues related to the cost, validity, precision, and utility of these methods must be carefully considered. The testis, the site of sperm cell production and the target organ for genetic damage, is most often studied. To establish the extent of toxicity to the testis, researchers can measure the size of the testis, obtain a semen sample, or take a testicular biopsy. Standard semen analyses (including semen volume, sperm concentration, total sperm count, motility, and morphology) have been the primary research tools for studying the effects of toxicants on the male reproductive system. Epidemiologic studies have successfully utilized semen quality as a marker of fertility (Fisch et al., 1997) . The uncertainties associated with traditional semen measures have led to the recent development of assays of sperm function and genetic integrity; these assays may prove more sensitive and more specific reflections of toxicant-induced effects (e.g., aneuploidy or reduced sperm motility) in individuals (Martin et al., 1997) . However, The accessory sex glands, which include the epididymis, prostate, and seminal vesicle, may also be targets of toxicants (Schrader, 1997) . Ethylene dibromide is one substance that affects the accessory sex glands after occupational exposure. Alterations in sperm viability, as measured by eosin stain exclusion or by hypo-osmotic swelling or alterations in sperm motility variables, suggest a problem with the accessory sex glands. Sperm density/Sperm count.
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Sperm morphology and morphometry 5.
Sperm motility (% of motile and velocity), Sperm viability (Vital stain and Hyper Osmotic Swelling (HOS)). 6.
Sperm function assays (Acrosome reaction, Hemizona assay of sperm binding and sperm penetration assay). 7.
Sperm genetic analysis (Sperm chromatin stability assay, Comet assay. Assessment of chromosomal aneuploidy and Nuclear microdeletions). 8.
Marker chemicals from accessory glands (Epididymis is represented by glycerylphosphorylcholine, Seminal vesicles by fructose, and the Prostate gland by zinc). 9.
Nocturnal penile measurements. 10.
Personal reproductive history (Pubertal development, Paternity (Pregnancy timing and outcomes), Sexual functions (Erection, Ejaculation, Orgasm and Libido)). evaluating marker chemicals secreted by each respective gland (Schrader, 1997) . For example, the epididymis is represented by glycerylphosphorylcholine, the seminal vesicles by fructose, and the prostate gland by zinc. Measures of semen pH and volume provide additional general information on the nature of seminal plasma, reflecting post testicular effects. A toxicant or its metabolite may act directly on accessory sex glands to alter the quantity or quality of their secretions. Alternatively, the toxicant may enter the seminal plasma and affect the sperm or may be carried to the site of fertilization by the sperm and affect the ova or conceptus. The presence of toxicants or their metabolites in seminal plasma can be analyzed using atomic absorption spectrophotometry or gas chromotography/mass spectrometry. Impact on the neuroendocrine system is another mechanism whereby toxicants can disturb the male reproductive system. To establish the extent of endocrine dysfunction, hormone levels can be measured in blood and urine. The profile recommended by NIOSH to evaluate endocrine dysfunction associated with reproductive toxicity consists of assessing serum concentrations of follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone, and prolactin (Schrader, 1997) . Because of the pulsatile secretion of LH, testosterone, and to a much lesser extent FSH, and the variability in the evaluation of reproductive hormones, it is recommended that three blood samples be drawn at set intervals in the early morning and the results pooled or averaged for clinical assessment. In epidemiologic field studies, however, multiple blood samples are impractical and may decrease participation rates. Alternatively, LH and FSH can be measured in urine, providing indices of gonadotropin levels that are relatively unaffected by pulsatile secretion. However, if an exposure can affect hepatic metabolism of sex steroid hormones (Apostoli et al., 1996) , urinary measures of excreted testosterone metabolite (androsterone) or estradiol metabolite (estrone-3-glucuronide) are not recommended. Moreover, future assessment of reproductive hormones may extend to inhibin, activin, and follistatin, polypeptides that are 
Biomarkers of genetic damage
Biomarkers of chromosomal and genetic damage are increasingly used in the search to understand abnormal reproductive health outcomes, in part because of the possibility that there may be identifiable genetic polymorphisms which make an individual more susceptible to the adverse reproductive effects from exogenous substances. These assays provide promising and sensitive approaches for investigating germinal and potentially heritable effects of exposures to agents and for confirming epidemiologic observations on smaller numbers of individuals. Efficient technology for examining chromosomal abnormalities in sperm has only been developed recently. Chromosomal abnormalities are primarily of two types: numerical and structural. Both kinds can be attributed in some cases to paternal factors. Karyotype studies have shown that although oocytes demonstrate a higher frequency of numerical chromosomal abnormalities, human sperm demonstrate a higher frequency of structural abnormalities with less frequent numerical abnormalities (Moosani et al., 1995) . In assessing sperm exposure to toxicants, it is therefore imperative to assess DNA structural integrity and not just chromosomal count. Aneuploidy is a chromosomal abnormality that causes pregnancy loss, perinatal death, congenital defects, and mental retardation. Aneuploidy, a disorder of chromosome count, is observed in approximately 1 in 300 newborns. It is speculated that of all species, humans experience the highest frequency of aneuploidy at conception, with estimates ranging from 20 to 50% (Moosani et al., 1995) . Spontaneous abortions occur in at least 10-15% of all clinically recognized pregnancies. Of these, 35% contain chromosomal aneuploidy. Despite such a high frequency, there is little information about what causes this abnormality in humans. Paternal origins of aneuploidy and other genetic abnormalities can be analyzed by studying chromosome complements in human sperm. Two types of analyses provide data on chromosomal abnormalities in human sperm: sperm karyotype analysis and fluorescence in situ hybridization (FISH) (Moosani et al., 1995) . Each technique has advantages and disadvantages. Sperm karyotyping is performed after sperm have fused with hamster oocytes. It provides precise information on numerical and gross structural abnormalities of all chromosomes from a given spermatozoon. However, only a limited number of sperm can be evaluated in each assay, and only those sperm that fertilize the oocytes are analyzable. Furthermore, this assay is technically difficult, labor intensive, expensive, and requires the use of animals. Also, it is better suited for clinical than for field studies because it must be performed on fresh semen. FISH, on the other hand, relies on the use of chromosomespecific probes to detect extra chromosomes (aneuploidy) or chromosome breaks or rearrangements in sperm. It is performed directly on sperm cells, eliminating the need for the use of animals. Although information is gained only for several chromosomes at a time, slides can be reprobed to increase the number of chromosomes evaluated. Furthermore, FISH can be conducted on archived sperm (either frozen or dried on slides), making it ideal for use in field studies. However, because the incidence of sperm aneuploidy is low, many cells (up to 10,000 per semen sample) must be evaluated, which requires significant scoring times. In comparison to karyotype analysis, however, FISH is relatively inexpensive and technically simpler, and data are obtained on all sperm, not just the ones that are capable of fertilization. These two techniques complement each other, with FISH providing information on large numbers of cells and karyotyping providing more precise and detailed information (Robbins et al., 1997 ).
Develop biomarkers of exposures and male reproductive health for research and clinical use
Resources must be invested in developing more advanced biomarkers of exposure to reproductive toxicants and of male reproductive health outcomes. Advanced biomarkers would allow for the development of toxicant-specific tests (e.g., polycyclic aromatic hydrocarbon-DNA adducts) and the detection of subclinical changes that might have significant health implications but which now go unnoticed by current measures. New biomarkers of semen quality are advantageous in that they can both describe male reproductive capacity and indicate toxic effects independent of the female partner's reproductive health. New tests could more accurately measure sperm function, fertilization potential, and the transmission of an intact male genome. Genetic testing may provide valuable tools for researchers and clinicians. For example, the sperm chromatin stability assay and FISH are used to assess genetic structure after exposure to a potential toxicant. Recently, single nucleotide polymorphisms have been used in the assessment of geneenvironment interactions.
Mechanism of male reproductive toxicity
The disruption of spermatogenesis may be represented by four mechanisms, including (1) epigenetic changes to the genome, (2) apoptosis of germ cells, (3) dysregulation of androgenic signaling, and (4) (retinoid X receptor)-and p21, and down-regulation of pRB, cyclin D, CDK2, cyclin E, and CDK4 (Ryu et al., 2007) . Neonatal estrogen treatment (DES, ethinyl estradiol [EE] ) increased apoptosis at all stages of spermatogenesis in the rat (Atanassova et al., 1999) . Thus, apoptosis is a likely mechanism for some mechanisms of endocrine disruption in the testis (Jana et al., 2010b) . Testicular androgenic signalling may be impaired via several mechanisms, including decreased Leydig cell population, impaired Leydig cell steroidogenesis, and dysregulation of the HPT axis. Abnormal development and maturation of the Leydig cell population reduces the steroidogenic potential of the testis. In utero exposure to phthalate esters is associated with morphological abnormalities of the male reproductive tract, including decreased anogenital distance, cryptorchidism, hypospadias, diminished Leydig cell population, and decreased testicular testosterone (Mylchreest et al., 2000; Fisher et al., 2003) . Phthalate esters such as DEHP are proposed to exert antiandrogenic and estrogenic mechanisms of action and disrupt hormone synthesis via an AhR pathway (Ge et al., 2007) . Low-dose BPA exposure in utero reduced the size of the epididymis and decreased anogenital distance and increased prostate size (Gupta, 2000) in adult mice. Leydig cell maturation and development include expression of genes related to endocrine signaling (LH receptors, AR) and steroidogenesis. Steroidogenesis is dependent on availability of cholesterol to the cytochrome P-450 cholesterol side chain cleavage (P450scc) enzyme complex within the mitochondria, the rate-limiting and regulated step in steroidogenesis (Miller, 1988) . Steroidogenic acute regulatory protein (StAR) is proposed as the candidate protein for the acute regulation of steroidogenesis. StAR transports cholesterol into the inner membrane, where steroidogenic enzymes catalyze consecutive reactions to convert cholesterol to testosterone in Leydig cells (Clark et al., 1994 , Jana et al., 2008 2010a; 2010b) . In utero exposure to exogenous estrogens (EE, DES, genistein, and BPA) downregulate expression of a number of testicular genes including Cyp17, Cyp11a, and StAR expression in the rat and mouse (Fielden et al., 2002) . The expression of a number of genes related to steroidogenesis (Scarb1, Star, Cyp11a1, HSD3b1, and CYP17a1) was altered following in utero exposure to di(n-butyl) phthalate (Barlow et al., 2003) . Testicular androgen signalling may also be impaired through suppression of normal HPT regulation of Leydig cell steroidogenesis. Disruption of the HPT axis, thereby reducing testicular testosterone levels, was demonstrated in the rat following exposure to a range of endocrine disrupters. Exposure to estrogens DES and EE also impaired HPT signalling in the rat, reducing plasma testosterone and increasing plasma FSH (Atanassova et al., 1999) . Both Leydig and Sertoli cells contain the enzyme aromatase and convert androgens to estrogens, thereby providing an intratesticular source of estrogens (O'Donnell et al., 2001). Atrazine, a herbicide with antiandrogenic and estrogenic properties, was found to produce a number of adverse reproductive effects in the rat. Atrazine has a low affinity for androgen and estrogen receptors, reduces androgen synthesis, and enhances estrogen production via the induction of aromatase (Sanderson et al., 2000) . Thus, testicular physiology is sensitive to perturbations of androgenic and estrogenic signalling, such that xenobiotic exposures might result in reduced fertility. Sertoli cell number is directly representative of the spermatogenic potential of the testis. Ablation of the Sertoli cell population, or loss of Sertoli cell function, is therefore another mechanism by which endocrine disrupters may impair spermatogenesis. Exposure to prenatal DES or EE reduced adult population of Sertoli cells in rats (Atanassova et al., 1999) and supports the hypothesis that in utero exposure to estrogens contributes to impaired spermatogenesis in the adult. It is also noteworthy that human spermatogenesis is much less efficient than in rodents, such that small decreases in the population of Sertoli cells would be expected to have large effects on male fertility in human. Estrogenic disruption of the testis is perhaps the most well characterized example of endocrine disruption of spermatogenesis; however, it is also worthy to note that estrogens play important roles in development of hormone responsive tissue, including Leydig cells and development and differentiation of the fetal male reproductive tract (Tsai-Morris et al., 1986). ERs, both alpha and beta (ER and ERß), are found throughout the male reproductive tract and represent a transcriptional mechanism by which endocrine disrupters may alter gene expression. (Haffner, 1996) and disruption of testicular androgen signaling by AhR ligands, PAH and nicotine, contained in tobacco smoke (Kizu et al., 2003) and many others. Further that, increasing evidence suggests an induction of oxidative stress in the testis represents another common response after exposure to environmental toxicants (Jana et al., 2010a (Jana et al., & 2010b . Increase in oxidative stress can be seen in ≤80% of clinically proven infertile men, and exposure to environmental toxicants is a major factor contributing to such an increase (Tremellen, 2008 Figure 5 ). Importantly, these observations were confirmed in studies illustrating that co-administration of antioxidants such as vitamin E with environmental toxicants could alleviate the pathophysiological effects (e.g. reduction in sperm count) of toxicants in the testis (Latchoumycandane & Mathur, 2002 ). These findings demonstrate that oxidative stress induced by environmental toxicants is one of the major contributing factors to male infertility. In fact, oxidative stress has long been linked to male infertility; although most studies have focused on its roles in causing abnormalities in germ cells and apoptosis (Sikka, . Furthermore, proinflammatory cytokines (e.g. IL-6 and TNF ) activate leukocytes to produce ROS, which amplifies the deleterious effects of environmental toxicant-induced oxidative stress (Tremellen, 2008) . The male reproductive system has emerged as one of the major targets of environmental toxicants. Although acute exposure to toxicants contributes to apoptosis and the necrosis of testicular cells, chronic and sub-lethal exposure is prevailing in the general public (Hauser & Sokol 2008) . Due to the unusually long half-lives of some of these toxicants in the mammalian body (e.g. cadmium has a mean half-life of >15 years), chronic and low-level exposure to humans could cause long-term unwanted health effects. The disruptive effects of environmental toxicants on cell junctions mediated by non-receptor tyrosine kinases (e.g. c-Src and FAK) and cytokines through oxidative stress because such damage is often observed in low-level exposure before apoptosis occurs (Li et al., 2006; Li et al., 2009 ). Significantly, these signalling pathways converge to utilize polarity proteins to regulate intercellular junctions. Polarity proteins (which are known to control cell adhesion in the testis) thus emerge as novel targets for therapeutic intervention to limit environmental toxicant-induced infertility. Although it is equally important to study the epigenetic (e.g. vinclozolin) and endocrine-disruptive (e.g. BPA, dioxin, cadmium) effects of environmental toxicants, it is increasingly clear that these toxicants are imposing an immediate deleterious effect in the testis via disruption of cell junctions between testicular cells due to increase in oxidative stress. In addition, endocrinedisrupting toxicants that affect estrogen levels might cause a disturbed balance of ROS and oxidative stress because estrogen is an important free-radical scavenger in humans, besides being essential for spermatogenesis (Carreau and Hess, 2010) . Recent studies have emphasized the importance of assessing the effects of a mixture of environmental toxicants on male reproductive function because humans are exposed to an array of chemicals that might antagonize or agonize each other (Hauser & Sokol 2008 Although this type of study is inherently difficult to undertake, it is crucial for a full understanding of the impact of environmental toxicants on the reproductive system. However, much work is needed to understand the precise molecular events and mechanism(s) regulated by environmental toxicants to target c-Src, FAK, MAPK and polarity proteins in the testis. Only then can we identify specific phosphorylation targets or isoforms so that small-molecule agonists and/or antagonists can be designed to limit systemic toxicity in vivo. 
Conclusions
In view of the fact that the preliminary concerns arose about environmental chemicals or toxins and declining sperm counts, there has been an explosion of research in this area. The initial 'environmental oestrogen' hypothesis has been superseded by a more refined definition of EDCs. It is now accepted that there are a plethora of ways in which the environmental chemicals can potentially act on the endocrine as well as male reproductive systems. Though supportive data must need to determine whether human male reproductive health is declining or not. However; the hypothesis of a 'testicular dysgenesis syndrome' is an important advancement and may aid our understanding of the underlying aetiology of these disorders. Within the reproductive tract, the male is exquisitely vulnerable to the effects of anti-androgens during development due the dependence on the synthesis and action of androgens for the masculinization of the male reproductive tract. The ability of phthalates to suppress androgen synthesis during development and to induce testicular dysgenesis together with cryptorchidism and hypospadias has close parallels with human TDS. However, the crucial question regarding whether the level of environmental chemicals is sufficient to impact on human male reproductive health remains unanswered, although advances will be made from studying the effects of multi-component EDC mixtures in both in vitro and in vivo test systems. Moreover, it has been observed that in wildlife, there is a increasing rates of testicular cancer, to the debate regarding trends in sperm counts, there has been increasing concern that hazardous substances in the environment adversely affect male reproductive health. The ultimate benefits of this chapter that should serve as a framework for future studies to improve our knowledge in this area. By better defining the problems, learning about the mechanisms responsible for adverse effects, and developing panels of relevant biomarkers, we will make progress toward preventing future adverse effects on male reproductive health.
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